Spanish Red Biotech Pipeline

QGENOMICS Quantitative Genomic Medicine Laboratories

qCancer: BRCA1/2, Mama, Gine, Colorrectal, Risk, Risk Expanded

Type: Biomarkers / Diagnostic
Therapeutic area: Cancer
Indication: NGS panels to detect the level of hereditary Cancer risk
Phase: 5Ready to Market, 4Register, 3Clinical validation, 2Preclinical Validation, 1R+D
Studies location: Spain